Human Vaccines and Immunotherapeutics 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 8, 2024 Category: Allergy & Immunology Authors: Hatim M. JaberSaja EbdahSameer A. Al Haj MahmoudLuay Abu-QatousehYazan H. Jabera Department of Community Medicine, Faculty of Medicine, Al-Balqa Applied University, Al-Salt, Jordanb Department of Biological Sciences, Jordan University, Amman, Jordanc Depa Source Type: research
A case of congenital rubella syndrome and epidemiology of related cases in China, 2014 –2023
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 8, 2024 Category: Allergy & Immunology Authors: Xiaoying GongCanjie ZhengQuanjun FangWenjie XuZhiying YinDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China Source Type: research
Misinformation and COVID-19 vaccine uptake hesitancy among frontline workers in Tanzania: Do demographic variables matter?
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 8, 2024 Category: Allergy & Immunology Authors: Juma James MaseleDepartment of General Management, University of Dar es Salaam Business School, Dar es Salaam, Tanzania Source Type: research
Opportunities and challenges for human papillomavirus vaccination in China
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 5, 2024 Category: Allergy & Immunology Authors: Chao ZhaoYun ZhaoJingran LiMingzhu LiYujing ShiLihui Weia Gynaecology, Peking University People ’s Hospital, Beijing, Chinab MRL Global Medical Affairs, MSD China, Shanghai, Chinac Department of Gynecology and Obstetrics, Peking University People’s Ho Source Type: research
Factors associated with pregnant women ’s willingness to receive maternal pertussis vaccination in Guizhou Province, China: An exploratory cross-sectional study
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 5, 2024 Category: Allergy & Immunology Authors: Feng JiangXingui YeYing WangNing TangJun FengYuanxue GaoMeiling Baoa Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Chinab School of Public Health, Fudan University, Shanghai, Chinac Source Type: research
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 5, 2024 Category: Allergy & Immunology Authors: Bradley K. AckersonKatia J. BruxvoortLei QianLina S. SySijia QiuJulia E. TubertGina S. LeeJennifer H. KuAna FloreaYi LuoRadha BathalaJulie SternSoon K. ChoiHarpreet S. TakharMichael AragonesMorgan A. MarksEvan J. AndersonCindy Ke ZhouTianyu SunCarla A. Ta Source Type: research
Rotavirus vaccine dose-two dropout and its associated factors among children who received rotavirus vaccine dose-one in Sub-Saharan African countries: A multilevel analysis of the recent demographic and health survey
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 5, 2024 Category: Allergy & Immunology Authors: Belayneh Shetie WorknehEnyew Getaneh MekonenAlebachew Ferede ZegeyeAlmaz Tefera GoneteTewodros Getaneh AlemuTadesse Tarik TamirBerhan TekebaMulugeta WassieAlemneh Tadesse KassieMohammed Seid Alia Department of Emergency and Critical Care Nursing, School o Source Type: research
Parents and teachers ’ perspectives on a school-located influenza vaccination program: A pilot study in the Region of Murcia, Spain
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 4, 2024 Category: Allergy & Immunology Authors: Matilde Zornoza MorenoJaime P érez-MartínMarta Robles Mañuecoa Health Prevention and Protection Service, General Directorate of Public Health and Addictions, Health Council, Region de Murcia, Spainb Immunotherapy and Vaccines Unit, AstraZeneca Farmacé Source Type: research
HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 3, 2024 Category: Allergy & Immunology Authors: Laura T éblickMarijana LipovacFreya MolenberghsPeter DelputteWinnok H. De VosAlex Vorstersa Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgiumb Laboratory of Cell Biology and Histolo Source Type: research
State of pneumococcal vaccine immunity
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 3, 2024 Category: Allergy & Immunology Authors: Mustafa AkkoyunluDivision of Bacterial Allergenic and Parasitic Diseases, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA Source Type: research
Available evidence on the co-administration of the four-component meningococcal B vaccine (4CMenB) with three vaccines at the same visit among pediatric individuals
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 3, 2024 Category: Allergy & Immunology Authors: Paolo BonanniStefano CastagnaGiovanni GabuttiSandro GiuffridaFederico MarchettiRocco RussoRosa PratoFrancesco Vitalea Dipartimento di Scienze della Salute, University of Florence, Florence, Italyb Medical Department, GSK, Verona, Italyc Coordinatore Nazio Source Type: research
High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 3, 2024 Category: Allergy & Immunology Authors: Pan LiuXiaohan YangHongyu ZhaoLihua LiangMinchai ChenAihua YinMedical Genetic Center, Guangdong Women and Children Hospital, Guangzhou, China Source Type: research
Understanding healthcare providers ’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 3, 2024 Category: Allergy & Immunology Authors: Salini MohantyJui-Hua TsaiNing NingAna MartinezRishi P. VermaMarieke HeisenJessica WeaverKristen A. FeemsterBianca ChunThomas W. WeissJordana K Schmiera Merck Research Laboratories, Merck & Co. Inc, Rahway, NJ, USAb Evidence & Access, OPEN Health, Bethe Source Type: research
Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 2, 2024 Category: Allergy & Immunology Authors: Peter KardosJaime Correia de SousaUlrich HeiningerAndreas KonstantopoulosC. Raina MacIntyreDonald MiddletonTerry NolanAlberto PapiAdrian RendonAlbert RizzoKim SampsonAlessandro SetteElizabeth SobczykTina TanCatherine Weil-OlivierBirgit WeinbergerTom Wilki Source Type: research
Unlocking cancer vaccine potential: What are the key factors?
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - April 2, 2024 Category: Allergy & Immunology Authors: Michael GrantLian Ni LeeSenthil ChinnakannanOrion TongJonathan KwokNicole CianciLuke TillmanAbhishek SahaVinnycius Pereira AlmeidaCarol Leunga Infinitopes Ltd, Oxford, UKb Oxford Health NHS Foundation Trust, Oxford, UKc University of Oxford, Oxford, UK Source Type: research
